Micro-RNAs • SIRT1 (silent mating type information regulation 2 homolog 1) • ROS (reactive oxygen species) • Ovarian Cancer Abstract Background: Metabolic abnormalities are frequently observed in multiple malignancies including epithelial ovarian cancer (EOC), among which imbalance between generation and elimination of reactive oxygen species (ROS) plays a critical role in EOC onset and progression. Here we investigated the role of miR-29b, a well-established tumor-suppressor miRNA in metabolic regulation of EOC cells. Methods: cell viability and apoptosis in miR-29b inhibited and over-expressed EOC cells were evaluated by CCK8 and Annexin V-FITC/PI assays. Change in miR-29b was detected in EOC cells incubated in H 2 O 2 culture by q-PCR. Relative ROS levels were also detected in different EOC cultures, including modified miR-29b and SIRT1 levels as well as H 2 O 2 incubation. A luciferase reporter assay was employed to detect the direct binding of miR-29b to SIRT1 3' UTR. Changes in cell viability and ROS levels were assessed in SIRT1-knocked down EOC cells. Results: miR-29b expression correlates with decreased EOC cell viability and increased apoptosis. H 2 O 2 downregulated miR-29b in a time and dose-dependent manner. miR-29b expression negatively correlated with ROS levels, whereas SIRT1 significantly stimulated ROS formation. Luciferase reporter assays confirmed miR-29b downregulation of SIRT1by directly targeting its mRNA 3'-UTR. SIRT1 silencing rescues cell viability of H 2 O 2 treated cells. Also, SIRT1 inhibition blocked cell apoptosis induced by H 2 O 2 as well as reduced intracellular ROS levels. Conclusion: Together, our findings indicated that the miR-29b/SIRT1 axis has a protective effect against H 2 O 2 -induced damage of cell viability and oxidative stress and may provide novel options for miR-29b-based therapeutic approaches for EOC treatment.
Mir
at late stages, with a 5-year survival rate of less than 30% [2] . Current standard treatment for EOC includes a combination of cytoreductive surgery and platinum-based chemotherapy, which acts efficiently as initial treatment. However, as treatment continues, most EOC patients recur and turn to be resistant to existing treatments [3] . Therefore, alternative approaches to the diagnosis and treatment of EOC patients are urgently needed. Exploration of novel biomarkers for early diagnosis, prognosis prediction, and effective therapies will definitely contribute to the current state of clinical care of EOC.
Reactive oxygen species (ROS) are a series of highly reactive molecules principally derived from the oxygen that is consumed in various metabolic activities occurring mainly in the mitochondria, peroxisomes, and the endoplasmic reticulum [4] . Regulation of intracellular ROS is critical for cellular homeostasis, since different ROS levels could lead to different biological responses.ROS at low and moderate levels acts as signaling molecules that sustain cellular proliferation, differentiation, and cell cycle progression as well as activate stress responsive survival pathways [5] . However, excessive ROS levels triggers severe cell damage and apoptosis pathways [6] . Accumulating evidence shows that excess generation of ROS elicits oxidative stress in cells and tissues and leads to various diseases, including various cancers [7] [8] [9] . Accumulated oxidative stress leads to a rise in ROS levels, which in hence activate oncogene signaling pathways and may further exploit underlying mutagenesis and genomic variability in cancer cells to stimulate cancer progression [10] . Increased ROS production is also a hallmark of EOC and ROS is suggested to be prosurvival and antiapoptotic in ovarian cancer cells [11] .
SIRT1 belongs to the sirtuins family of NAD+-dependent histone/protein deacetylases, which has been frequently reported to regulate diverse cellular processes including antioxidative stress, cell differentiation, cell survival, cell cycling, and metabolism by deacetylating downstream targets [12] . SIRT1 has been found to be expressed in various tissues, including ovaries [13] . In our previous studies, we focused on exploring the versatile roles of miR-29b in EOC onset and progression, and found that miR-29b plays vitals roles in regulating energy metabolism, mesenchymal transition, as well as epigenetic regulation of ovarian cancer cells [14] [15] [16] . Noticeably, using bioinformatics, we previously identified SIRT1 as potential downstream target gene of miR-29b, indicating that miR-29b is probably involved in cancerous ROS manipulation by targeting SIRT1 signaling pathway. However, so far there is no research available on whether miR-29b plays a role in the oxidative stress during ovarian cancer. We believe that elaborating both the specific roles of miR-29b in the oxidative stress of ovarian cancer and the latent molecular mechanisms will further our theoretical understanding of human ovarian cancer as well as provide future clinical approaches to treating EOC.
Materials and Methods

Cell lines
The human ovarian cancer cell lines SKOV3 and A2780(both obtained from ATCC, Manassas, VA,USA) were maintained in high-glucose DMEM (Gibco,Invitrogen, Carlsbad, CA, USA) supplemented with 10%(v/v) fetal bovine serum at 37°C in a humidified 5% CO 2 atmosphere.
Bioinformatics analysis
Potential targets and binding sites of miR-29b werepredicted using several online programs, includingmiRanda(http://www.microrna.org/microrna/home.do),miRBase (http://www.mirbase. org/index.shtml), miRWalk(http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/index.html), and TargetScan (http://www.targetscan.org/); SIRT1 was predicted to be a downstream targetgene of miR-29b by all of these softwares, and this wasfurther validated by experiments.
Cell transfection
The control mimics, miR-29b mimics, control inhibitors, and miR-29b inhibitors were all purchased from RiboBio (Guangzhou, China). SIRT1targeted siRNAs, SIRT1 adenoviruses (SIRT1-Ad), and their respec-Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry tive negative controls were purchased from GenePharma(Shanghai, China). Transfection of ovarian cancer cells were conducted as described previously [14] . 48 h after transfection, the cells were collected for further experiments.
Quantitative real-time PCR qPCR was performed as depicted before [10] . In brief, total RNA was collected using TRIzol reagent(Invitrogen, Carlsbad, CA, USA). First-strand cDNA was synthesized usingPrimeScript RT reagent kit(Perfect Real Time; Takara, Dalian, China). qPCR was then performed using SYBR PremixEx Taq™ II (Takara) on a CFX96 real-time PCR System(Bio-Rad, Hercules, CA, USA). β-actin was used as an internal control for results normalization.miR-29b levels were detected using a TaqMan microRNA kit (Applied Biosystems) and normalized to small nuclear RNA (Rnu6),which was taken as a control. The data were expressed as Log 2-fold changes relative to miRs/U6 snRNA levels. The primers for miR-29b and U6 reverse transcription and amplification were designed by and purchased from RiboBio Co., Ltd. (Guangzhou, China). All primers used are listed in Table 1 .
Western blot analysis
Cell lysates were collected using mammalian protein extraction reagent (Pierce, Rockford, IL, USA) with protease inhibitors (Roche, Indianapolis, IN,USA). The protein concentration of each sample was determined using a BCA-200 protein assay kit (Pierce, Rockford, IL, USA). The proteins were resolved on 10% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were blocked in blocking buffer (5% non-fat milk in TBST). Mouse anti-humanSIRT1 (ab110304, Abcam, Cambridge, UK), and mouse anti-human β-actin (#3700S, CST, MA, USA) were incubated with the membranes overnight at 4°Cat dilutions of 1:800, and 1:2000,respectively. After washed with TBST, the blots were visualized with anti-rabbit or anti-mouse IgG conjugated with peroxidase (HRP) and ECL reagents (Pierce, Rockford, IL, USA).
Cell viability assay
The viability of EOC cells was determined using the cell counting kit-8 (CCK-8) assay (Beyotime Institute of Biotechnology, Beijing, China), according to the manufacturer's protocols. Briefly, cells were seeded into 96-wellplates (3000 cells/well). After being incubated in 10 µl CCK-8for 2 hours, the absorbance of each well was measured at 450 nm (Tecan Infinite M200 microplatereader; LabX, Austria). All of the experiments were performed at leastin triplicate.
Measurement of apoptosis
To detect cell apoptosis, EOC cells were stained with AnnexinV-fluoresce in isothiocyanate (FITC) and counterstained with propidium iodide (PI) using the Annexin V-FITC/PIapoptosis detection kit (BD PharMingen, San Diego, CA,USA), according to the manufacturer's protocols. Briefly, the cells were treated as indicated, trypsinized, and harvested by centrifugation. Then, the cells were incubated with annexin V and PI for 15 min at room temperature in the dark. Analyses were performed using FACScan cytometer (BD Biosciences, Woburn, MA,USA) and FlowJo software (BD Biosciences).
Intracellular Reactive Oxygen Species (ROS) Assay
EOC cells were grown to confluence in a 24-well plate and then transfected with miRNAs, siRNAs, and adenoviruses, and cultured for48 h. H 2 O 2 (400 µM) was added for the last 2 h. The cells were then labeled with 2',7'-dichlorofluorescin-diacetate(DCFH-DA, Sigma) at 37∘C for 30 min and readings were performed using FACScan cytometer (BD Biosciences, Woburn, MA,USA). Luciferase reporter assay Luciferase reporter assay was performed as depicted before [15] . Briefly, The SIRT1 3'UTR containing the predicted miR-29b target sequence was amplified from EOC cell genomic DNA and cloned into the pGL3 firefly luciferase control vector (Promega, Madison, WI) at the XhoI restriction site directly downstream of the reporter gene. To generateSIRT1 3'UTR with a mutant target sequence, transversion mutations of 7 nucleotides were made at themiR-29b seed region complementary sites as shown in Fig. 3C . Inhibition of the luciferase reporter gene levels by miR-29b was assessed in SKOV3and A2780 cells as indicated before [15] . The results were manifested as percentage change over the respective control.
Statistical analysis
All of the experiments were performed at least in triplicate and each experiment was independently performed at least 3 times. Data were presented as mean ± standard deviation (SD) and analyzed using GraphPad Prism 5 software. Statistical significance was assessed using two-tailed unpaired Student's t-test. When a P value was less than 0.05, the differences were considered as statistically significant.
Results
miR-29b expression correlates with decreased EOC cell viability and increased apoptosis.
As illustrated before, miR-29b has been found to be a versatile player in EOC onset and progression, correlated with cell differentiation, migration, energy metabolism, as well as epigenetic regulation [14] [15] [16] . Here, CCK-8 assay was taken to evaluate the role of miR-29b in EOC cell survival. As shown in Fig. 1 , over-expression of miR-29b reduced cell survival, while inhibition of miR-29b expression enhanced cell survival in both EOC cell lines (Fig.  1A) . According to flow cytometric analysis (Fig.1B) , miR-29b mimic-treated EOC cells were significantly more apoptotic than their NC mimics counterparts. However, miR-29b inhibition via target inhibitor transfection led to a decrease in EOC cell apoptosis. These results support our hypothesis that overexpression of miR-29b correlates with decreased EOC cell viability and increased apoptosis. 
Effects of H
adaptation to stress which leads to neoplastic transformation while high levels of H 2 O 2 induce cell death [4] . In order to test the correlation between miR-29b and ROS in EOC cells, here we evaluated the expression of miR-29b in both EOC cell lines treated with H 2 O 2 for different periods of time. As indicated in Fig. 2A Fig. 2C , H 2 O 2 incubation dramatically enhanced cellular ROS generation, miR-29b expression negatively correlated with ROS levels, whereas SIRT1 significantly stimulated ROS formation (Fig. 2C) .
miR-29b directly targets negatively SIRT1.
Intriguingly, modifications in miR-29b and SIRT1 led to opposite changes in ROS levels (Fig. 2C) , which encouraged us to explore the underlying connection between miR-29b and SIRT1. We employed micro-RNA mimics and inhibitors to specifically overexpress and knock down the endogenous expression of miR-29b in A2780 as well as SKOV3 cells. As shown in Fig. 3A and 3B, SIRT1 expression was significantly decreased by transfection with miR-29b mimics and was greatly increased by transfection with miR-29b inhibitors at both the mRNA and protein level. Therefore, miR-29b negatively regulates SIRT1 expression in both selected EOC cell lines. We then employed bioinformatics software (including miRanda,Targetscan, miRBase, and miRWalk) for a prediction of miR-29b downstream targets. By analyzing the 3'-UTR sequence of SIRT1 as well as the mature chain sequence of miR-29b, we found that the seed region in the miR-29b mature chain is fully complementary with and thus potentially binds to the SIRT1 3'UTR sequence (Fig. 3C ). This observation suggested that miR-29b might negatively regulate SIRT1 level by directly binding to its 3'UTR sequences. Finally, the direct binding between miR-29b and SIRT1 3'UTR was confirmed by the 3'UTR luciferase reporter assay. In brief, ovarian cancer cells were transfected with control or (Fig. 3D) . Only transfection of the wild-type SIRT1 3'UTR significantly decreased luciferase expression, and this suppressive effect of miR-29b was later abolished by mutating the miR-29b site in SIRT1 3'UTR (Fig. 3E) . Collectively, miR-29b was observed to directly bind to its complementary sequence motifs in the SIRT1 3'UTR, thus negatively regulating its level. Cell
siRNA-mediated downregulation of SIRT1 enhanced the viability and attenuated ROS production in ovarian cancer cells.
In the previous experiment, we observed H 2 O 2 downregulated the expression ofmiR29b and miR-29b/SIRT1 direct targeting, next we explore whether SIRT1 plays a role in miR29b-induced EOC cells viability and oxidative stress. We downregulated SIRT1 expression in A2780 cells treated with H 2 O 2 using siRNA transfection. As demonstrated in Fig. 4A , cell viability was rescued under the H 2 O 2 treatment in siRNA-mediatedSIRT1knocked-down cells. Besides, SIRT1 inhibition also blocked the cell apoptosis induced by H 2 O 2 (Fig. 4B) . Further, SIRT1 knockdown reduced intracellular ROS levels (Fig. 4C) . Together, our findings indicated that the miR-29b/SIRT1 axis has a protective effect againstH 2 O 2 -induced damage of cell viability and oxidative stress.
Discussion
Our results show that overexpression of miR-29b is strongly associated with lower viability and increased apoptosis in EOC cells. miR-29b is also found to be decreased in a ROS-dependent manner. This study strongly suggests that miR-29b is a promising candidate for a more optimized target for EOC therapy.
In recent decades, various roles of miRNAs have been explored in diverse physiological and pathological activities, including tumorigenesis [17] [18] [19] [20] [21] . For instance, miR-34a has been observed to mediate multiple cancerous pathways by targeting crucial genes in tumorigenesis including P53, PDGFR, and c-MET, etc [22] . miR-29b, a well-established tumor-suppressor miRNA, has been found to be dysregulated in various human cancers, including ovarian cancer [14] [15] [16] 23 ]. In the current study, we showed miR-29b's role in modulating cell viability and apoptosis. A negative correlation was observed between miR29b and SIRT1, a crucial regulator in cellular oxidative stress. We further confirmed that miR-29b regulates SIRT1 by directly targeting its 3'UTR sequences, which adds a novel role for miR-29b as a ROS regulator in EOC development. Of note, our data are in agreement with previous reports demonstrating that miR-29s is capable of regulating SIRT1 in agerelated hearing loss and self-renewal of mouse embryonic stem cells, adding a novel role of the tumor suppressor miRNA miR-29b in cancerous oxidative stress [24, 25] . Intriguingly, recent studies have observed a panel of differentially expressed miRNAs in urines of ovarian cancer patients as compared to healthy control [26] . Superior to blood to some extent, urine is the ideal bio-fluid for the biomarker detection for it allows non-invasive collection. Thus, further study may focus on detecting the specific expression patterns of miR-29b in urines of EOC patients and control, aiming to explore the possibility of miR-29b as a non-invasive biomarker for EOC screening.
ROS are byproducts of biological reactions of energy generation, which are mainly produced in the mitochondria throughout the process of oxidative metabolism [27, 28] . The balance between ROS generation and elimination is crucial for cell survival, while imbalance of ROS level triggers oxidative damage which in hence exerts discrepant impacts on cancer cell survival and causes final cell death by various mechanisms. Since ROS are generated during ovulation, oxidative stress has been proposed as a cause of ovarian cancer [29] . Actually, the association between ovarian cancer and oxidative stress has been repeatedly identified in the past decades [30] [31] [32] . Compared with other ROS, H 2 O 2 is a relatively longlived molecule commonly used to represent cellular ROS levels. As demonstrated in our study, incubation of H 2 O 2 dramatically enhanced cellular ROS level, indicating that the dynamic oxidant/antioxidant balance is perturbed following the addition of exogenousH 2 O 2 to cultured cells. Also, treatment of EOC cells with H 2 O 2 caused a dose and time-dependent decrease in miR-29b levels of EOC cells, suggesting miR-29b close involvement in EOC oxidative metabolism. Accumulating studies have revealed that ROS can alter the expression of certain miRNAs [33, 34] . The mechanism underlying ROS-regulated microRNA expression is complicated and poorly understood. The major proposed mechanisms so far include that Cellular Physiology and Biochemistry
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ROS regulates microRNA biogenesis enzymes, through transcription factors, and through epigenetic modification [35] . Further exploration is needed to reveal underlying mechanism of ROS regulation of miR-29b in EOC cells. SIRT1, identified as a direct downstream target of miR-29b, belongs to the Sirtuins family of NAD + -dependent histone deacetylases, which controls cellular activities and maintains metabolic homeostasis by reducing apoptosis, attenuating inflammation, and modulating oxidative stress [36] . SIRT1 activation led to beneficial effects in metabolic disorders involving diabetes, cardiovascular disease, as well as tumorigenesis [37, 38] . Hence, regulating SIRT1 should be beneficial in treating cancerous diseases. Indeed, regulation of SIRT1 by miRNAs has been suggested [39] . For instance, miR-9 directly targets and lowers SIRT1 expression, leading to inhibited cell proliferation in AE-positive AML cell lines [40] . miR-141 targets Sirt1 and inhibits autophagy to reduce HBV replication, which could be taken as a target to lower the possibility of developing liver cirrhosis and hepatocellular carcinoma [41] . In this study, we observed a decrease in miR-29b levels in H 2 O 2 -treated EOC cells. miR-29b and SIRT1 exerted opposite effects on cell viability. Luciferase assays later determined the direct targeting of SIRT1 by miR-29b. Decreased SIRT1 expression attenuated ROS production in H 2 O 2 -treated EOC cells. SIRT1 has been found to regulate various well-established tumorigenic pathways, like Wnt-β catenin and PI3K/Akt [42] [43] [44] . Intriguingly, in our previous study, we have revealed miR-29b direct targeting and negative regulation of AKT2/3 and their roles in aberrant EOC metabolism [15] . Thus, interaction between miR-29b, AKT2/3, and SIRT1 and the underlying molecular mechanism DNMT3A/3B-Id-1 interaction, as well as their shares in EOC development call for further exploration in future study.
Conclusion
The data obtained in the present study indicated that with a complementary structure, miR-29b combines and thus negatively regulates SIRT1. miR-29b expression correlates with EOC cell viability and apoptosis, which may be regulated by ROS production. The findings together raised the possibility that miR-29b/SIRT1axis may be potent options for future clinical treatments of ovarian cancer.
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